The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.

Novo Nordisk will soon require its staff to work in the office full-time after it cut thousands of jobs. The Ozempic maker ...

At their heights, Denmark’s corporate champions seemed untouchable. Novo Nordisk A/S, long known mostly as an insulin maker, was Europe’s most valuable company last year, after riding a surge of ...

Novo Nordisk, the Danish pharmaceutical company known for its weight-loss drug Wegovy and diabetes medicine Ozempic, has ...

Novo Nordisk - makers of Ozempic - is set to lay off 9,000 staff members, or 11.5 % of its workforce. Five thousand of the ...

There are fears Denmark is facing a so-called “Nokia risk”. Read more at straitstimes.com. Read more at straitstimes.com.

Danish drugmaker warns over slowing growth as Ozempic and Wegovy producer faces pressure from US rival Eli Lilly ...

Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to reignite ...

Novo, which has 78,400 positions globally, said about 5,000 of the job cuts will be in its native Denmark. Read more at ...